Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with metabolic syndrome

Circulation Journal

Volumn 72, Issue 4, 2008, Pages 551-557

  Dongxia, Liu ^a   Qi, Hua ^a   Lisong, Liu ^a   Jincheng, Guo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Insulin resistance; Metabolic syndrome; PPAR polymorphism

Indexed keywords

ALANINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CHINA; CHINESE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EXON; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HOMOZYGOTE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA GENE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHINA; DNA PRIMERS; EXONS; FEMALE; GENE FREQUENCY; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA;

EID: 43549093036     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.551     Document Type: Article

References (40)

1. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
3. Ballantyne CM, Olsson AG, Cook TJ, Mercuri MF, Pedersen TR, Kjekshus J. For the Scandinavian Simvastatin Survival Study(4s) Group: Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease and response to simvastatin therapy in 4s. Circulation 2001; 104: 3046-3051.
4. Mayer EJ, Newman B, Austin MA, Zhang D, Quesenberry CP Jr, Edwards K, et al. Genetic and environmental influences on insulin levels and the insulin resistance syndrome: An analysis of women twins. Am J Epidemiol 1996; 143: 323-332.
5. Hong Y, Pedersen NL, Brismar K, de Faire U. Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet 1997; 60: 143-152.
6. Yamada Y. Identification of genetic factors and development of genetic risk diagnosis systems for cardiovascular diseases and stroke. Circ J 2006; 70: 1240-1248.
7. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645-650.
8. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992; 68: 879-887.
9. Fajas L, Fruchart JC, Auwerx J. PPARγ 3 mRNA: A distinct PPARγ mRNA subtype transcribed from an independent promoter. FEBS Lett 1998; 438: 55-60.
10. Sundvold H, Lien S. Identification of a novel peroxisome proliferatoractivated receptor (PPARγ) promoter in man and transactivation by the nuclear receptor RORα1. Biochem Biophys Res Commun 2001; 287: 383-390.
11. Rhee EJ, Kwon CH, Lee WY, Kim SY, Jung CH, Kim BJ, et al. No association of Pro12Ala polymorphism of PPAR-gamma gene with coronary artery disease in Korean subjects. Circ J 2007; 71: 338-342.
12. Mancini FP, Vaccaro O, Sabatino L, Tufano A, Rivellese AA, Riccardi G, et al. Pro12Ala substitution in the peroxisome proliferatoractivated receptor-γ2 is not associated with type 2 diabetes. Diabetes 1999; 48: 1466-1468.
13. Ringel J, Engeli S, Distler A, Sharma AM. Pro12Ala missense mutation of the peroxisome proliferator activated receptorγ and diabetes mellitus. Biochem Biophys Res Commun 1999; 254: 450-453.
14. Clement K, Hercberg S, Passinge B, Galan P, Varroud-Vial M, Shuldiner AR, et al. The Pro115Gln and Pro12Ala PPARγ gene mutations in obesity and type 2 diabetes. Int J Obes Relat Metab Disord 2000; 24: 391-393.
15. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS, et al. Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin dependent diabetes mellitus. Int J Obes Relat Metab Disord 2000; 24: 195-199.
16. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, et al. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet 1998; 7: 435-440.
17. Ogawa S, Urano T, Hosoi T, Miyao M, Hoshino S, Fujita M, et al. Association of bone mineral density with a polymorphism of the peroxisome proliferator-activated receptor gamma gene: PPARgamma expression in osteoblasts. Biochem Biophys Res Commun 1999; 260: 122-126.
18. Valve R, Sivenius K, Miettinen R, Pihlajamäki J, Rissanen A, Deeb SS, et al. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. J Clin Endocrinol Metab 1999; 84: 3708-3712.
19. Poulsen P, Andersen G, Fenger M, Hansen T, Echwald SM, Vølund A, et al. Impact of two common polymorphisms in the PPAR gamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: Thrifty genotype, thrifty phenotype, or both? Diabetes 2003; 52: 194-198.
20. Wang XL, Oosterhof J, Duarte N. Peroxisome proliferator-activated receptor gamma C161T polymorphism and coronary artery disease. Cardiovasc Res 1999; 44: 588-594.
21. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: A global public health problem and a new definition. J Atheroscler Thromb 2005; 12: 295-300.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostatsis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.
23. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410.
24. Hara K, Okada T, Tobe K, Yasuda K, Mori Y, Kadowaki H, et al. The Pro12Ala polymorphismin PPAR gamma2 may confer resistance to type 2 diabetes. Bioche Biophy Res Commun 2000; 271: 212-216.
25. Rhee EJ, Oh KW, Lee WY, Kim SY, Oh ES, Baek KH, et al. Effects of two common polymorphisms of peroxisome prolrferator-activated receptor-γ gene on metabolic syndrome. Archives Medical Research 2006; 37: 86-94.
26. Chuang LM, Hsiung CA, Chen YD, Ho LT, Sheu WH, Pei D, et al. Sibling-based association study of the PPAR2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: A SAPPHIRe study. J Mol Med 2001; 79: 656-664.
27. Tönjes A, Scholz M, Loeffler M, Stumvoll M. Association of Pro12Ala polymorphism in peroxisome proliferator activted-receptor γ with pre-diabetic phenothpes: Meta-analysis of 57 studies on non-diabetic individuals. Diabetes Care 2006; 29: 2489-2497.
28. Rosen ED, Spiegelman BM. PPARgamma: A nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001; 276: 37731-37734.
29. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997; 241: 270-274.
30. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287.
31. González Sánchez JL, Serrano Ríos M, Fernández Perez C, Laakso M, Martínez Larrad MT. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol 2002; 147: 495-501.
32. Frederiksen L, Brødbaek K, Fenger M, Jørgensen T, Borch-Johnsen K, Madsbad S, et al. Comment: Studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: Homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab 2002; 87: 3989-3992.
33. Song H, Shojima N, Sakoda H, Ogihara T, Fujishiro M, Katagiri H, et al. Resistin is regulated by C/EBPs, PPARs, and signal-transducing molecules. Biochem Biophys Res Commun 2002; 299: 291-298.
34. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, et al. The mechanisms by which both heterozygous peroxisome proliferators-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. J Biol Chem 2001; 276: 41245-41254.
35. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46: 3-10.
36. Ochoa MC, Marti A, Azcona C, Chueca M, Oyarzábal M, Pelach R, et al; Groupo de Estudio Navarro de Obesidad Infantil (GENOI). Gene-gene interaction between PPAR gamma 2 and ADR beta 3 increases obesity risk in children and adolescents. Int J Obes Relat Metab Disord 2004; 28: S37-S41.
37. Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, Werman A, Pories WJ, Caro JF, et al. Proxisome proliferator-activated receptor gene expression in human tissues: Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 1997; 99: 2416-2422.
38. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A medrod for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
39. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002; 19: 527-534.
40. Hrebícek J, Janout V, Malincíková J, Horáková D, Cízek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002; 87: 144-147.